The work of University of Illinois Cancer Center members, leaders, trainees, staff and community partners is featured during the San Antonio Breast Cancer Symposium (SABCS), which runs through December 9. About 10,000 clinicians and scientists come from around the globe to Texas to attend the annual event cosponsored by UT Health San Antonio’s Mays Cancer Center and the American Association for Cancer Research (AACR).

Below is the list of featured work with Cancer Center connections. The full SABCS program can be found here.

PO1-02-11 Characterization of MammaPrint UltraLow Risk tumors in more than 1400 patients from the real-world evidence FLEX study.

Cathy Graham (1) Kent Hoskins (2) Vijayakrishna K. Gadi (3) Suzanne Hoekstra (4) Gordon Srkalovic (5) Douglas Marks (6) Beth Sieling (7) Patricia Dauer (8) Andrea Menicucci (9) William Audeh (8) Joyce O’Shaughnessy (10) FLEX Investigators’ Group (11) (1) Emory University;(2) University of Illinois Chicago;(3) University of Illinois;(4) Northern Light Mercy Breast Care;(5) Sparrow Hospital System;(6) NYU Long Island School of Medicine; NYU Langone Hospital Long Island;(7) Trinity Health of New England;(8) Agendia Inc.;(9) Agendia Inc;(10) Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas, United States;(11) Agendia.

PO1-06-09 Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers Big Ten Cancer Research Consortium BTCRC-BRE18-337.

Sneha Phadke (1) Kari Wisinski (2) Oana Danciu (3) Ami Shah (4) Menggang Yu (5) Yi Chen (6) Kathy Miller (7) Mark Burkard (8) (1) University of Iowa, Iowa city, Iowa, United States;(2) University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States;(3) University of Illinois Cancer Center;(4) Northwestern University – Feinberg School of Medicine;(5) University of Wisconsin Carbone Cancer Center;(6) University of Wisconsin-Madison;(7) Indiana University;(8) Department of Medicine University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States

PO5-08-06 Metabolic shift to serine pathway induced by lipids confers oncogenic properties in nontransformed breast cells.

Mariana Bustamante Eduardo (1) Gannon Cottone (2) Shiyu Liu (3) Maria Paula Zappia (4) Elizaveta V. Benevolenskaya (4) Abul Bashar Mir Md. Khademul Islam (4) Maxim V. Frolov (4) Seema Khan (5) Susan Clare (6) (1) Surgery, Breast Surgery Division; Feinberg School of Medicine;(2) Northwestern University;(3) Duke University;(4) University of Illinois at Chicago;(5) Northwestern University, Chicago, Illinois, United States;(6) Surgery, Breast Surgery Division, Feinberg School of Medicine.

PO5-10-09 Capturing Experiences: Navigating Breast Cancer Treatment of Nigerian Patients and Healthcare Providers Using Qualitative Interviews.

Blessing Nwachukwu (1) Elizabeth Papautsky (2)

PO5-12-01 Characteristics of Patients Served by Participants in a Survivorship Navigator Learning Collaborative.

Tamara Hamlish (1) Talia Holzman Castellands (1) (1) University of Illinois at Chicago, Chicago, USA, Illinois, United States.

PO5-20-04 A Phase II Study of Ribociclib and Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study).

Oana Danciu (1) Nancy Chan (2) Kari Wisinski (3) Trish Millard (4) Kathleen Kemmer (5) Sneha Phadke (6) Zhengjia Chen (7) Ana Cuesta Fernandez (8) Melanie Clark (9) Alison Conlin (10) Coral Omene (11) Sima Ehsani (12) Stephanie Dublis (13) Vijayakrishna K. Gadi (7) (1) University of Illinois Cancer Center;(2) NYU;(3) University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States;(4) University of Virginia;(5) University of Michigan;(6) University of Iowa Hospitals and Clinics;(7) University of Illinois;(8) Orlando Health;(9) Parkview;(10) Providence Cancer Institute;(11) Rutgers Cancer Institute of New Jersey;(12) University of Arizona;(13) University of Michigan Health West.

PO5-20-05 The FOR ME (Fostering Opportunities in Research through Messaging and Education) study: Using multiple qualitative methods to develop a culturally sensitive narrative intervention to promote equity in clinical trials.

Neha Hippalgaonkar (1) Ryan Nguyen (1) Leslie Carnahan (2) Vida Henderson (3) Tigist Mersha (4) Eliza Cohn (3) Kauthar Salum (3) Ana Williams (4) Lolita Coleman (5) Beulah Brent (5) AnneMarie Murphy (6) Paris Thomas (6) Paramjeet Khosla (7) Kent Hoskins (1) (1) University of Illinois Chicago;(2) The University of Illinois at Chicago;(3) Fred Hutchinson Cancer Center;(4) University of Illinois at Chicago;(5) Sisters Working It Out;(6) Equal Hope;(7) Mt. Sinai Hospital.

Translate »